Search results
Results from the WOW.Com Content Network
Nausea and vomiting such that weight loss and dehydration occur [1] Duration: Often gets better but may last entire pregnancy [2] Causes: Unknown. [3] New research (late 2023) indicates an elevated level of one specific hormone. Risk factors: First pregnancy, multiple pregnancy, obesity, prior or family history of hyperemesis gravidarum ...
A previous proximal DVT or pulmonary embolism requires a minimum of 26 weeks (6.5 months) of therapy [13] If the therapy duration reaches delivery time, the remaining duration may be given after delivery, possibly extending the minimum of six weeks of post partum therapy. [13]
Pregnancy Category: D D . Has the highest propensity of all anticonvulsants for causing birth defects. Around 6-11% of children born to mothers that used the drug during pregnancy are born with birth defects. Oral Ziprasidone and treatment as usual: 55.1: 14.1 ++/+ -
The pulmonary embolism rule-out criteria (PERC) helps assess people in whom pulmonary embolism is suspected, but unlikely. Unlike the Wells score and Geneva score , which are clinical prediction rules intended to risk stratify people with suspected PE, the PERC rule is designed to rule out the risk of PE in people when the physician has already ...
The enlarging uterus, growing fetus, placenta, amniotic fluid, normal increase in body fat, and increase in water retention all contribute weight gain during pregnancy. The amount of weight gain can vary from 5 pounds (2.3 kg) to over 100 pounds (45 kg). In the United States, the range of weight gain that doctors generally recommend is 25 ...
The Geneva score is a clinical prediction rule used in determining the pre-test probability of pulmonary embolism (PE) based on a patient's risk factors and clinical findings. [1] It has been shown to be as accurate as the Wells Score , and is less reliant on the experience of the doctor applying the rule. [ 2 ]
Having a first DVT (deep vein thrombosis) or PE (pulmonary embolism) before age 50. Having recurring DVT or PE. Having venous thrombosis in unusual sites in the body such as the brain or the liver. Having a DVT or PE during or right after pregnancy. Having a history of unexplained pregnancy loss in the second or third trimester.
Streptokinase is a thrombolytic medication activating plasminogen by nonenzymatic mechanism. [1] As a medication it is used to break down clots in some cases of myocardial infarction (heart attack), pulmonary embolism, and arterial thromboembolism. [2]